Evolution of intratumoral genetic heterogeneity during colorectal cancer progression.
暂无分享,去创建一个
Lorena Losi | J. Benhattar | L. Losi | B. Baisse | H. Bouzourène | Hanifa Bouzourene | Bénédicte Baisse | Jean Benhattar
[1] M. Hawn,et al. Prognostic significance of allelic lost at chromosome 18q21 for stage II colorectal cancer. , 1998, Gastroenterology.
[2] 福成 博幸. Intratumoral heterogeneity of genetic changes in primary colorectal carcinomas with metastasis , 2004 .
[3] K. Kinzler,et al. Genetic instabilities in human cancers , 1998, Nature.
[4] W. Giaretti,et al. Intratumor heterogeneity of K-ras2 mutations in colorectal adenocarcinomas: association with degree of DNA aneuploidy. , 1996, The American journal of pathology.
[5] K. Kinzler,et al. Lessons from Hereditary Colorectal Cancer , 1996, Cell.
[6] Martin A. Nowak,et al. The significance of unstable chromosomes in colorectal cancer , 2003, Nature Reviews Cancer.
[7] N. Konishi,et al. Intratumor cellular heterogeneity and alterations in ras oncogene and p53 tumor suppressor gene in human prostate carcinoma. , 1995, The American journal of pathology.
[8] S. Cascinu,et al. Prognostic molecular markers for planning adjuvant chemotherapy trials in Dukes' B colorectal cancer patients: how much evidence is enough? , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[9] B. Bapat,et al. Genomic instability and cancer. , 2003, Current molecular medicine.
[10] J. Benhattar,et al. Microdissection by exclusion and DNA extraction for multiple PCR analyses from archival tissue sections. , 2000, BioTechniques.
[11] T. Owonikoko,et al. Intratumoral genetic heterogeneity in Barrett adenocarcinoma. , 2002, American journal of clinical pathology.
[12] B. Vogelstein,et al. A genetic model for colorectal tumorigenesis , 1990, Cell.
[13] R. Orecchia,et al. Intratumor heterogeneity of chromosome 1, 7, 17, and 18 aneusomies obtained by FISH and association with flow cytometric DNA index in human colorectal adenocarcinomas. , 1999, Cytometry.
[14] L. Sobin,et al. TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.
[15] D. Ledbetter,et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. , 1989, Science.
[16] B. Iacopetta,et al. The common molecular genetic alterations in Dukes' B and C colorectal carcinomas are not short‐term prognostic indicators of survival , 1994, International journal of cancer.
[17] F T Bosman,et al. Intratumor genetic heterogeneity in advanced human colorectal adenocarcinoma , 2001, International journal of cancer.
[18] A. Jauch,et al. Intratumoral genomic heterogeneity in advanced head and neck cancer detected by comparative genomic hybridization. , 2005, Advances in Oto-Rhino-Laryngology.
[19] A. Norman,et al. Kirsten ras mutations in patients with colorectal cancer: the multicenter "RASCAL" study. , 1998, Journal of the National Cancer Institute.
[20] S. Altschul,et al. Identification of FAP locus genes from chromosome 5q21. , 1991, Science.
[21] G. Thomas,et al. Association of p53 mutations with short survival in colorectal cancer. , 1994, Gastroenterology.
[22] J W Arends,et al. Molecular interactions in the Vogelstein model of colorectal carcinoma , 2000, The Journal of pathology.
[23] N. Carter,et al. Array Comparative Genomic Hybridization Analysis of Colorectal Cancer Cell Lines and Primary Carcinomas , 2004, Cancer Research.
[24] Kathleen R. Cho,et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. , 1990, Science.
[25] B. Iacopetta,et al. Prognostic significance of TP53 gene mutation in 995 cases of colorectal carcinoma. Influence of tumour site, stage, adjuvant chemotherapy and type of mutation. , 2000, European journal of cancer.
[26] B. Vogelstein,et al. Prevalence of ras gene mutations in human colorectal cancers , 1987, Nature.
[27] C. Langner,et al. Pitfalls in diagnostic molecular pathology – significance of sampling error , 2001, Virchows Archiv.
[28] M. Duffy,et al. Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines. , 2003, European journal of cancer.